T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo cocktail shows promise for rare blood cancers
Disease control Recruiting nowThis study tests a combination of several chemotherapy drugs plus nelarabine in people with untreated T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. The goal is to see how well this treatment works at stopping cancer growth and improving survival. About 160 partic…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
New combo therapy aims to wipe out leukemia in adults who Can't handle standard Kids' regimens
Disease control Recruiting nowThis study tests a chemotherapy cocktail (DA-EPOCH) plus an enzyme drug (Rylaze) in 30 adults newly diagnosed with a type of leukemia (Ph-negative ALL) who are not good candidates for the intensive regimens used in children. The goal is to see if this combination can clear cancer…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 14, 2026 12:03 UTC